Study GSI-136 in Healthy Young and Healthy Elderly Subjects
Status:
Completed
Trial end date:
2008-08-01
Target enrollment:
Participant gender:
Summary
This is a first-in-humans study of GSI-136, a drug being developed for the treatment of
Alzheimer Disease. The main purpose of this study is to determine whether GSI-136 is safe and
tolerable in healthy young and healthy elderly subjects. The amount of drug in the body and
the effects of the drug on the body will also be evaluated at certain timepoints.